Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,197,000 | 6,597,000 | 5,668,000 | 4,953,000 | 4,273,000 |
| Depreciation Amortization | 1,869,000 | 1,662,000 | 1,605,000 | 1,592,000 | 1,510,000 |
| Income taxes - deferred | -720,000 | -74,000 | -106,000 | -128,000 | -26,000 |
| Accounts receivable | -685,000 | -516,000 | -159,000 | -427,000 | -607,000 |
| Other Working Capital | 1,331,000 | -198,000 | 1,592,000 | 420,000 | 163,000 |
| Other Operating Activity | 1,603,000 | 705,000 | 264,000 | 493,000 | 607,000 |
| Operating Cash Flow | $10,595,000 | $8,176,000 | $8,864,000 | $6,903,000 | $5,920,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,927,000 | -1,943,000 | -1,568,000 | -1,523,000 | -1,767,000 |
| Net Acquisitions | -2,812,000 | -478,000 | -225,000 | -151,000 | -271,000 |
| Purchase Of Investment | -7,590,000 | -6,923,000 | -8,188,000 | -5,676,000 | -3,832,000 |
| Sale Of Investment | 8,062,000 | 7,353,000 | 5,967,000 | 4,827,000 | 3,057,000 |
| Other Investing Activity | -259,000 | -206,000 | -79,000 | -142,000 | -280,000 |
| Investing Cash Flow | $-4,526,000 | $-2,197,000 | $-4,093,000 | $-2,665,000 | $-3,093,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,062,000 | 2,359,000 | 338,000 | 814,000 | 3,208,000 |
| Debt Issued | 1,023,000 | 22,000 | 14,000 | 591,000 | 793,000 |
| Debt Repayment | -196,000 | -245,000 | -391,000 | -35,000 | -187,000 |
| Common Stock Issued | 311,000 | 390,000 | 514,000 | 387,000 | 221,000 |
| Common Stock Repurchased | -1,183,000 | -6,538,000 | -2,570,000 | -973,000 | -840,000 |
| Dividend Paid | -2,746,000 | -2,381,000 | -2,047,000 | -1,724,000 | -1,479,000 |
| Other Financing Activity | -4,134,000 | -560,000 | -1,109,000 | -1,485,000 | -4,063,000 |
| Financing Cash Flow | $-3,863,000 | $-6,953,000 | $-5,251,000 | $-2,425,000 | $-2,347,000 |
| Exchange Rate Effect | 277,000 | 110,000 | -40,000 | -47,000 | -72,000 |
| Beginning Cash Position | 2,894,000 | 3,758,000 | 4,278,000 | 2,512,000 | 2,104,000 |
| End Cash Position | 5,377,000 | 2,894,000 | 3,758,000 | 4,278,000 | 2,512,000 |
| Net Cash Flow | $2,483,000 | $-864,000 | $-520,000 | $1,766,000 | $408,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,595,000 | 8,176,000 | 8,864,000 | 6,903,000 | 5,920,000 |
| Capital Expenditure | -2,262,000 | -2,099,000 | -1,731,000 | -1,689,000 | -1,822,000 |
| Free Cash Flow | 8,333,000 | 6,077,000 | 7,133,000 | 5,214,000 | 4,098,000 |